Katiyar Kritika S, Struzyna Laura A, Morand Joseph P, Burrell Justin C, Clements Basak, Laimo Franco A, Browne Kevin D, Kohn Joachim, Ali Zarina, Ledebur Harry C, Smith Douglas H, Cullen D Kacy
Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Center for Neurotrauma, Neurodegeneration & Restoration, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, United States.
Front Bioeng Biotechnol. 2020 May 25;8:492. doi: 10.3389/fbioe.2020.00492. eCollection 2020.
Strategies to accelerate the rate of axon regeneration would improve functional recovery following peripheral nerve injury, in particular for cases involving segmental nerve defects. We are advancing tissue engineered nerve grafts (TENGs) comprised of long, aligned, centimeter-scale axon tracts developed by the controlled process of axon "stretch-growth" in custom mechanobioreactors. The current study used a rat sciatic nerve model to investigate the mechanisms of axon regeneration across nerve gaps bridged by TENGs as well as the extent of functional recovery compared to nerve guidance tubes (NGT) or autografts. We established that host axon growth occurred directly along TENG axons, which mimicked the action of "pioneer" axons during development by providing directed cues for accelerated outgrowth. Indeed, axon regeneration rates across TENGs were 3-4 fold faster than NGTs and equivalent to autografts. The infiltration of host Schwann cells - traditional drivers of peripheral axon regeneration - was also accelerated and progressed directly along TENG axons. Moreover, TENG repairs resulted in functional recovery levels equivalent to autografts, with both several-fold superior to NGTs. These findings demonstrate that engineered axon tracts serve as "living scaffolds" to guide host axon outgrowth by a new mechanism - which we term "axon-facilitated axon regeneration" - that leads to enhanced functional recovery.
加快轴突再生速度的策略将改善周围神经损伤后的功能恢复,特别是对于涉及节段性神经缺损的病例。我们正在推进组织工程神经移植物(TENGs)的研究,该移植物由通过定制机械生物反应器中轴突“拉伸生长”的受控过程形成的长而排列整齐的厘米级轴突束组成。当前的研究使用大鼠坐骨神经模型来研究轴突通过TENGs桥接的神经间隙再生的机制,以及与神经导向管(NGT)或自体移植相比功能恢复的程度。我们确定宿主轴突生长直接沿着TENG轴突发生,这通过提供加速生长的定向线索,模仿了发育过程中“先驱”轴突的作用。事实上,TENGs上的轴突再生速度比NGTs快3到4倍,与自体移植相当。宿主雪旺细胞(周围轴突再生的传统驱动因素)的浸润也加速了,并直接沿着TENG轴突进展。此外,TENG修复导致的功能恢复水平与自体移植相当,两者均比NGTs高出几倍。这些发现表明,工程化轴突束作为“活体支架”,通过一种新机制——我们称之为“轴突促进轴突再生”——引导宿主轴突生长,从而导致功能恢复增强。